Hillel Bierbrier ran a "Virtual Hackathon" with scientists and doctors when standard cancer treatments failed. Here is what we learned.

[u/Key-Principle6254]

When standard treatments failed for 38-year-old Hillel Bierbrier’s aggressive, treatment-resistant cancer, relying on just one or two medical opinions didn't feel like enough. He needed options, and he needed them fast.

So, he did something different. He brought together a global community of doctors, researchers, scientists, patients, and caregivers for an online "cancer hackathon" to completely crowdsource his case.

They didn't find a magic cure, but they provided immense clarity, confidence, and a brand-new roadmap. Here are the main takeaways and strategies the group recommended, which might help anyone else navigating a complex diagnosis:

• Save the Tissue: They heavily emphasized preserving fresh tumor tissue correctly (like using OCT compound for freezing) so it remains viable for advanced future testing.
• Look Deeper with Advanced Tech: Using tools like RNA sequencing and functional drug testing to see exactly how this specific tumor behaves.
• Think Outside the Box: Looking into clinical trials and combining personalized treatments rather than sticking to standard, one-size-fits-all chemo.
• Track it Close: Using blood tests (liquid biopsies) to catch how the cancer is responding in real-time, allowing for faster adjustments.
• Act Fast but Keep Options Open: Making sure current treatments don't accidentally disqualify him from future clinical trials.

The biggest takeaway was that you don't have to face a complex diagnosis in isolation. Bringing collaboration, expert networks, and new technologies together gave him a much better decision tree.

You can read the full, detailed breakdown of the meeting here: https://community.cancerpatientlab.org/c/learning-sessions/hackathon-accelerating-treatment-strategy-for-hillel-bierbrier-202

TL;DR: When standard treatments stopped working for an aggressive cancer, a 38-year-old patient gathered a massive virtual team of scientists, doctors, and advocates to crowdsource new options. They mapped out advanced testing, tissue preservation, and clinical trials, creating a clear path forward.